The global facial injectables market is expected to reach USD 17.2 billion by 2025,
according to a new report by Grand View Research, Inc. The market is expected
to exhibit lucrative growth during the forecast period, owing to advancements
in facial rejuvenation procedures and increasing importance of medical
aesthetics across the globe.
Development in products
& procedures, as well as change in patient demographics is helping
dermatologists and physicians treat multiple facial areas. These advancements
help dermatologists or physicians develop customized treatment for patients and
facilitate use of combination products to obtain better outcomes. All these
factors are expected to assist in the market growth over the forecast period.
Augmented products such as Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid
(HA) fillers are used in combination to improve outcomes, especially in the
lower face procedures. HA fillers are mostly preferred by physicians due to
their better acceptance (few instances of hypersensitivity reactions),
biodegradable nature, & high viscosity as well as for the longevity they
provide to the restored volume.
Minimally invasive
surgery, an advanced medical technology, is used for facial rejuvenation,
endoscopy, laparoscopy, arthroscopy and other procedures. This procedure is
gaining popularity over time owing to faster recovery, low instances of
postsurgery infections, lower pain, reduced scarring, and high accuracy &
maximum benefits. For instance, as per International Society of Aesthetic
Plastic Surgery (ISAPS), more than 20.0 million surgical and nonsurgical
cosmetic procedures were performed worldwide in 2014.The number of HA-based surgeries
performed in 2014 was 2,690,633, which increased to 2,865,086 in 2015, which is
thereby expected to contribute to the growth of this space over the forecast
period.
Access Research Report of Facial Injectables Market@:
Further key findings from the study suggest:
· The hyaluronic acid segment held a
lucrative share in 2016 and is expected to grow at a significant rate over the
forecast period owing to increasing preference for combination treatments such
as hyaluronic acid with BoNTA.
· The BoNTA segment is anticipated to witness
the fastest growth over the forecast period due to increasing application in
aesthetics and therapeutics
· The aesthetics segment is expected to
dominate the market during the forecast period owing to increasing expenditure
on aesthetic procedures coupled with rising beauty consciousness among
consumers
· North America is expected to dominate the
facial injectables market over the forecast period due to growing geriatric
population base, increasing consumer disposable income, and surge in number of facial
procedures in the region
· Some of the key players in facial
injectables market are ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.;
Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited;
Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma
S.A.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global facial injectables market on the basis of product,
application, and region:
Facial Injectables Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Collagen
·
Hyaluronic Acid (HA)
·
Botulinum Toxin Type A
·
Calcium Hydroxylapatite (CaHA)
·
Polymer Fillers
o
Polymethylmethacrylate Beads (PMMA
Microspheres)
o
Poly-L-lactic acid (PLLA)
Facial Injectables Application Outlook (Revenue, USD
Million, 2014 - 2025)
·
Aesthetics
·
Therapeutics
Facial Injectables Regional Outlook (Revenue, USD
Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa (MEA)
o
South Africa
Access Press Release of
Facial Injectables Market @: www.grandviewresearch.com/press-release/global-facial-injectables-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment